Who is sponsoring NCT03389464?

NCT03389464 is sponsored by University of Regensburg.

What drugs are being tested in NCT03389464?

Interventions in NCT03389464: computer-based confrontation with dysfunctional beliefs.

What condition does NCT03389464 study?

NCT03389464 studies Depression.

Is NCT03389464 still recruiting?

NCT03389464 is currently status unknown. Last updated 2 May 2018.

Last reviewed 2018-05-02 · How we verify

NCT03389464

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Computer-based Treatment of Dysfunctional Beliefs in Depressive Inpatients

Status unknown NA Last updated 2 May 2018

What this trial tests

NA trial testing computer-based confrontation with dysfunctional beliefs in Depression in 60 participants. Status unknown.

Timeline

8 January 2018

Primary endpoint
27 September 2018

27 September 2018

Quick facts

Lead sponsor	University of Regensburg
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	60
Start date	8 January 2018
Primary completion	27 September 2018
Estimated completion	27 September 2018
Sites	1 location across Germany

Drugs / interventions tested

computer-based confrontation with dysfunctional beliefs

Conditions studied

Depression — all drugs for Depression →

Sponsor

University of Regensburg

Who can join

Adults 18 to 65, any sex, with Depression. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the present study is to investigate whether confronting depressive patients with their dysfunctional core beliefs via a computer program results in a reduction of the patients' dysfunctional beliefs. Patients will be presented with a virtual agent confronting them with their dysfunctional core beliefs (e.g. "You are worthless"). Participants will be instructed to contradict these virtual agents (e.g. "That's not true, I'm a wonderful person").

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Computer-Assisted Avatar-Based Treatment for Dysfunctional Beliefs in Depressive Inpatients: A Pilot Study.
Kocur M, Dechant M, Wolff C, Nothdurfter C, et al · · 2021 · cited 6× · PMID 34335319 · DOI 10.3389/fpsyt.2021.608997

Verify or expand the search:

Other recruiting trials for Depression

Currently open trials in the same condition.

NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or · Phase 2 · recruiting
NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression · EARLY_PHASE1 · recruiting
NCT07517549 — Sexual Health Education During Pregnancy · NA · recruiting
NCT06408246 — ACE-D Aim 3 Clinical Cognitive Trial to Enhance Translation in Depression · Phase 2 · recruiting
NCT07449676 — Effects of an Innovative TCM-based Tui Jing Therapy on Psychological and Neurophysiological Functions in Depression · NA · recruiting

Other University of Regensburg trials

Trials by the same sponsor.

NCT07444242 — Accelerated Treatment of Depressive Patients With tDCS · NA · not yet recruiting
NCT06766214 — Attexis and tDCS for the Treatment of ADHD · NA · completed
NCT06689592 — Mobile Transcranial Magnetic Stimulation · NA · completed
NCT06520865 — TIDE Project: Biomarker Discovery for Chronic Tinnitus Diagnosis · completed
NCT06212895 — Expectations of Patients Regarding Exercise in an Outpatient Clinic · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03389464 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Regensburg
Last refreshed: 2 May 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03389464.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing